Zelong Liu
Author
Alternate names Zelong Liu, Ze‐Long Liu
Institution Harbin Institute of Technology
Past institutions Sun Yat-sen University, Sun Yat-sen University Cancer Center, Massachusetts General Hospital, Harvard University, Harbin Institute of Technology +2 more
ORCID: Yes
H-index: 7
I10-index: 5
Works count: 60
Citations count: 145
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma
2022 · Sui Peng, Shuling Chen, et al. · Cancer Immunology Research
Expressions and prognostic values of the <em>E2F</em> transcription factors in human breast carcinoma
2018 · Zelong Liu, Xi-Wen Bi, et al. · Cancer Management and Research
Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience
2019 · Zelong Liu, Xi-Wen Bi, et al. · Cancer Research and Treatment
93.4%
57
| Cholangiocarcinoma and Gallbladder Cancer Studies | 47 |
| Immunotherapy and Immune Responses | 5 |
| Lymphoma Diagnosis and Treatment | 3 |
| interferon and immune responses | 2 |
| Hepatocellular Carcinoma Treatment and Prognosis | 1 |
| preprint | 39 |
| supplementary-materials | 12 |
| article | 8 |
| review | 2 |
| book-chapter | 0 |